Table 5.
Prevalence of DR among people with diabetes and the full sample population
| n | Persons with diabetes % (95% CI) | Full sample % (95% CI) | |
|---|---|---|---|
| Retinopathy grade | |||
| No retinopathy (R0) | 162 | 80.6% (75.5-85.7) | 5.1% (4.3-5.9) |
| Background DR - mild (R1) | 3 | 1.5% (0.0-3.1) | 0.1% (0.0-0.2) |
| Background DR - observable (R2) | 4 | 2.0% (0.1-3.9) | 0.1% (0.0-0.2) |
| Background DR - referable (R3) | 10 | 5.0% (1.8-8.1) | 0.3% (0.1-0.5) |
| Proliferative DR (R4) | 6 | 3.0% (0.4-5.6) | 0.2% (0.0-0.4) |
| Ungradable DR (R6) | 7 | 3.5% (0.7-6.2) | 0.2% (0.0-0.4) |
| Any retinopathy | 30 | 14.9% (10.3-19.5) | 0.9% (0.6-1.3) |
| Maculopathy grade | |||
| No maculopathy (M0) | 167 | 83.1% (77.8-88.4) | 5.2% (4.5-6.0) |
| Maculopathy - observable (M1) | 5 | 2.5% (0.4-4.6) | 0.2% (0.0-0.3) |
| Maculopathy - referable (M2) | 9 | 4.5% (1.7-7.3) | 0.3% (0.1-0.5) |
| Any maculopathy | 25 | 12.4% (8.0-16.9) | 0.8% (0.5-1.1) |
| Any retinopathy and/or maculopathy | 38 | 18.9% (13.7-24.1) | 1.2% (0.8-1.6) |
| Sight threatening DR (R4 and/or M2) | 12 | 6.0% (2.6-9.4) | 0.4% (0.1-0.6) |
| Any laser scars | 11 | 5.5% (2.3-8.6) | 0.3% (0.1-0.5) |
DR=Diabetes retinopathy